ANNEX IU.K. TEMPLATE COVER LETTER ACCOMPANYING A CONSULTATION REQUEST FOR DETERMINATION OF THE NOVEL FOOD STATUS
Competent authority of the Member State
Date: …
Subject: Consultation request for determination of the novel food status of …
…
The Food business operator(s)/consulting party:
Company: …
Address: …
Telephone: …
Email: …
Contact person: …
submit(s) the present consultation request in order to determine the novel food status of …
Yours sincerely,
Signature …
Enclosures:
☐
Documents in support of the consultation request
ANNEX IIU.K. TEMPLATE TECHNICAL DOSSIER
The connection between the different pieces of information shall be explained in an explanatory note. In particular, as regards the evidence presented to support a human consumption to a significant degree within the Union before 15 May 1997, where documents from a range of sources must be considered to be able to reach a conclusion.
Where only parts of the documents are relevant for the determination of the novel food status, those parts shall be highlighted.
For all foods, Section 1 must be completed.
For extracts, in addition to Section 1, Section 2 must be completed.
For foods resulting from a production process not used for food production within the Union before 15 May 1997, Section 1 (points 1 to 3, and point 7) and Section 3 must be completed.
Section 1: All foods (for foods resulting from a production process not used for food production within the Union before 15 May 1997 only points 1 to 3 and point 7)
1. Description of the food |
1.1Name of the food | |
1.2Detailed description of the food, including information whether the food consists of engineered nanomaterials as referred to in points (a)(viii) and (ix) of Article 3(2) of Regulation (EU) 2015/2283 (1) | |
1.3Proposed category of the novel food in accordance with Article 3(2)(a) of Regulation (EU) 2015/2283, where applicable | |
2. Further characterisation of the food and/or source of the food (where relevant) |
| A. Organisms (microorganisms, fungi, algae, plants, animals) |
|---|
2.1Taxonomic name (full Latin name with author name) | |
2.2Synonyms, other names, where applicable | |
2.3Specification of which part of the organism the use for human consumption before 15 May 1997 within the Union refers to, where applicable | |
2.4Specification about purity/concentration | |
| B. Chemical substances |
|---|
2.5CAS number(s) (if this has been attributed) | |
2.6Chemical name(s) according to IUPAC nomenclature rules | |
2.7Synonyms, trade name, common name, where applicable | |
2.8Molecular and structural formulae | |
2.9Specification about purity/concentration | |
3. Conditions of use |
3.1How is the food intended to be used? | |
3.2Type of product(s) in which the food is intended to be used | |
3.3Level/concentration (or range of levels) in the product(s) in which the food is intended to be used | |
4. Production process |
4.1Detailed description of the production process. Include a flow process chart to describe the production process. | |
5. History of human consumption of the food within the Union before 15 May 1997 |
5.1To what extent was the food consumed to a significant degree throughout the Union before 15 May 1997? Details shall be provided. | |
5.2To what extent was the food consumed to a significant degree in one Member State before 15 May 1997? Details shall be provided. | |
5.3Was the food consumed only regionally/on a small local scale in the Union before 15 May 1997? Details shall be provided. | |
5.4Was the food available before 15 May 1997 in the Union as an ingredient designed for specific target population (e.g. food for a special medical purpose)? Details shall be provided. | |
6. Consultations on availability in the Union Where food business operators are unsure whether the information in their possession is sufficient to prove that the food concerned has been used for human consumption to a significant degree within the Union before 15 May 1997, they may consult other food business operators or food business operator federations in order to gather sufficient information.
|
6.1Have other food business operators or food business operator federations been consulted? Details should be provided. | |
6.2Is the food currently available on the market within the Union? Details should be provided. | |
7. Additional information |
7.1Is there any information that the product concerned is used within the Union as medicinal product in accordance with Directive 2001/83/EC (2)? | |
7.2Is there any other information which would assist in determining the novel food status? Any information which is relevant even if not specifically requested shall be submitted. | |
Section 2: Extracts
8. Extracts |
8.1Any further details of the source material for the extract, if not provided in Section 1. Details shall be provided. | |
8.2Specification of the extract. Details shall be provided. | |
8.3If extracted from a food source, will the intake of any extract components in the food be higher than the intake of these components in the food source? Details shall be provided. | |
Section 3: Foods resulting from a production process not used for food production within the Union before 15 May 1997
9. Production process |
9.1Detailed description of the production process. Include a flow process chart to describe the production process. | |
9.2Is the structure or composition of the food affecting its nutritional value, metabolism or level of undesirable substances because of the process by which the food has been prepared? Details shall be provided. | |
9.3Is the food produced from a source that in itself is not normally consumed as part of the diet? Details shall be provided. | |
(1)Regulation (EU) 2015/2283 of the European Parliament and of the Council of 25 November 2015 on novel foods, amending Regulation (EU) No 1169/2011 of the European Parliament and of the Council and repealing Regulation (EC) No 258/97 of the European Parliament and of the Council and Commission Regulation (EC) No 1852/2001 (OJ L 327, 11.12.2015, p. 1).U.K.
(2)Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ L 311, 28.11.2001, p. 67).U.K.